BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37979591)

  • 21. Performance evaluation of SARS-CoV-2 antigen detection in the post-pandemic era: multi-laboratory assessment.
    Chen Y; Feng L; Han Y; Zhao Z; Diao Z; Huang T; Ma Y; Feng W; Li J; Li Z; Liu C; Chang L; Li J; Zhang R
    Clin Chem Lab Med; 2023 Nov; 61(12):2237-2247. PubMed ID: 37377068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the comparability of cycle threshold values derived from five external quality assessment rounds for omicron nucleic acid testing.
    Fan G; Jin Y; Wang Q; Yue Y
    Virol J; 2023 Jun; 20(1):119. PubMed ID: 37291570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples.
    Buchta C; Camp JV; Jovanovic J; Puchhammer-Stöckl E; Strassl R; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2022 Jul; 60(8):1308-1312. PubMed ID: 35599330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments.
    Buchta C; Kollros D; Jovanovic J; Huf W; Delatour V; Puchhammer-Stöckl E; Mayerhofer M; Müller MM; Shenoy S; Griesmacher A; Aberle SW; Görzer I; Camp JV
    J Clin Virol; 2023 Jan; 158():105352. PubMed ID: 36525853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
    Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
    Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of German external quality assessment schemes for SARS-CoV-2 antigen detection.
    Vierbaum L; Wojtalewicz N; Grunert HP; Zimmermann A; Scholz A; Goseberg S; Kaiser P; Duehring U; Drosten C; Corman V; Niemeyer D; Rabenau HF; Obermeier M; Nitsche A; Michel J; Puyskens A; Huggett JF; O'Sullivan DM; Busby E; Cowen S; Vallone PM; Cleveland MH; Falak S; Kummrow A; Schellenberg I; Zeichhardt H; Kammel M
    Sci Rep; 2023 Aug; 13(1):13206. PubMed ID: 37580353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inter-laboratory testing as a strategy for external quality assessment for qualitative detection of SARS-CoV-2 by real-time RT-PCR testing in India.
    Kaur H; Mukhopadhyay L; Aggarwal N; Gupta N; Narayan J; Vijay N; Gupta S; Rana S; Kaur J; Kumar V; Singh H
    Indian J Med Res; 2022 Jan; 155(1):86-90. PubMed ID: 35859435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021.
    Mögling R; Colavita F; Reimerink J; Melidou A; Leitmeyer K; Keramarou M; Lapa D; Francalancia M; Murk JL; Vossen A; Carletti F; Hogema B; Meijer A; Deprez L; di Caro A; Castilletti C; Reusken CB
    Euro Surveill; 2022 Oct; 27(42):. PubMed ID: 36268736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide external quality assessment of SARS-CoV-2 nucleic acid amplification tests in Japan.
    Asai S; Seki A; Akai Y; Tazawa H; Kakizoe H; Ravzanaaadii MA; Miyachi H
    Int J Infect Dis; 2022 Feb; 115():86-92. PubMed ID: 34800690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Mirror Technology Facilitates High-Throughput, Accurate SARS-CoV-2 Testing.
    Realegeno S; Hash S; Wong C; Liu R; Shepherd J; Schooley RT; Lipson DA; Fung F; Menon S; Pride DT
    Microbiol Spectr; 2021 Sep; 9(1):e0039221. PubMed ID: 34431687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pooled testing for COVID-19 diagnosis by real-time RT-PCR: A multi-site comparative evaluation of 5- & 10-sample pooling.
    Praharaj I; Jain A; Singh M; Balakrishnan A; Dhodapkar R; Borkakoty B; Ashok M; Das P; Biswas D; Kalawat U; Turuk J; Sugunan AP; Prakash S; Singh AK; Barathidasan R; Subhadra S; Sabat J; Manjunath MJ; Kanta P; Mudhigeti N; Hazarika R; Mishra H; Abhishek K; Santhalembi C; Dikhit MR; Vijay N; Narayan J; Kaur H; Giri S; Gupta N
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):88-94. PubMed ID: 32893844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A semi-automated, isolation-free, high-throughput SARS-CoV-2 reverse transcriptase (RT) loop-mediated isothermal amplification (LAMP) test.
    Schmidt J; Berghaus S; Blessing F; Wenzel F; Herbeck H; Blessing J; Schierack P; Rödiger S; Roggenbuck D
    Sci Rep; 2021 Nov; 11(1):21385. PubMed ID: 34725400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of SARS-CoV-2 RNA and nucleocapsid concentrations in samples used in INSTAND external quality assessment schemes.
    Valiente E; Falak S; Kummrow A; Kammel M; Corman VM; Macdonald R; Zeichhardt H
    BMC Res Notes; 2023 Sep; 16(1):210. PubMed ID: 37697348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. External quality assessment survey for SARS-CoV-2 nucleic acid amplification tests in clinical laboratories in Tokyo, 2021.
    Sugishita Y; Moriuchi R; Ishii Y
    J Infect Chemother; 2024 Jul; 30(7):633-641. PubMed ID: 38325625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A localized small-scale external quality assessment (EQA) for PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the molecular laboratories.
    Li RH; Wang QY
    J Virol Methods; 2022 Mar; 301():114441. PubMed ID: 34954305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development, deployment and in-field demonstration of mobile coronavirus SARS-CoV-2 Nucleic acid amplification test.
    Paton TF; Marr I; O'Keefe Z; Inglis TJJ
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33856292
    [No Abstract]   [Full Text] [Related]  

  • 39. Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic.
    Meredith LW; Aboualy M; Ochola R; Ozel M; Abubakar A; Barakat A
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13217. PubMed ID: 38019698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020-2022.
    Pasotti F; Pellegrinelli L; Liga G; Rizzetto M; Azzarà G; Da Molin S; Lungu OL; Greco S; Galli C; Bubba L; Pariani E; Corradin M; Cereda D; Buoro S
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.